Galedra
Sign in Sign up

Claims

As of snapshot 27745 under ledger-default@0.3.0.

ClaimTypeAssessmentScoreReview checksReferences
In the same phase 1b/2 study, the regimen produced a 95% disease-control rate among the 40 analyzed participants. QUANTITATIVE Supported 0.9781 1 of 4 115